Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3147)
All Articles published online
|
Jun 21, 2007 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Larsen FS, Vainer B, Eefsen M, Bjerring PN, Hansen BA. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. World J Gastroenterol 2007; 13(23): 3232-3236 [PMID: 17589903 DOI: 10.3748/wjg.v13.i23.3232] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i23/3232.htm |
| Number | Citing Articles |
| 1 |
A. M. C. Baven‐Pronk, M. J. Coenraad, H. R. van Buuren, R. A. de Man, K. J. van Erpecum, M. M. H. Lamers, J. P. H. Drenth, A. P. van den Berg, U. H. Beuers, J. den Ouden, G. H. Koek, C. M. J. van Nieuwkerk, G. Bouma, J. T. Brouwer, B. van Hoek. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Alimentary Pharmacology & Therapeutics 2011; 34(3): 335 doi: 10.1111/j.1365-2036.2011.04727.x
|
| 2 |
Albert J Czaja, Yusuf Bayraktar. Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment. World Journal of Gastroenterology 2009; 15(19): 2314-2328 doi: 10.3748/wjg.15.2314
|
| 3 |
V.M. Navas López, J. Blasco Alonso, C. Sierra Salinas, A. Barco Gálvez, M.I. Vicioso Recio. Eficacia y seguridad de tacrolimus oral para el tratamiento de la enfermedad inflamatoria intestinal pediátrica. Anales de Pediatría 2009; 70(6): 519 doi: 10.1016/j.anpedi.2009.03.005
|
| 4 |
Andréanne N. Zizzo, Pamela L. Valentino, Prakesh S. Shah, Binita M. Kamath. Second‐line Agents in Pediatric Patients With Autoimmune Hepatitis. Journal of Pediatric Gastroenterology and Nutrition 2017; 65(1): 6 doi: 10.1097/MPG.0000000000001530
|
| 5 |
C R Grant, B S Holder, R Liberal, M A Heneghan, Y Ma, G Mieli-Vergani, D Vergani, M S Longhi. Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis. Clinical and Experimental Immunology 2017; 189(1): 71 doi: 10.1111/cei.12956
|
| 6 |
Kenneth R Snider, Teresa G Potter. Budesonide for the Treatment of Autoimmune Hepatitis. Annals of Pharmacotherapy 2011; 45(9): 1144 doi: 10.1345/aph.1Q244
|
| 7 |
Albert J Czaja. Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut and Liver 2016; 10(2): 177 doi: 10.5009/gnl15352
|
| 8 |
Andrew D. Yeoman, Rachel H. Westbrook, Yoh Zen, Paola Maninchedda, Bernard C. Portmann, John Devlin, John G. O'Grady, Phillip M. Harrison, Michael A. Heneghan. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology 2011; 53(3): 926 doi: 10.1002/hep.24141
|
| 9 |
Hind I. Fallatah, Hisham O. Akbar. Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview. Autoimmune Diseases 2012; 2012: 1 doi: 10.1155/2012/312817
|
| 10 |
Marta Casal Moura, Rodrigo Liberal, Hélder Cardoso, Ana Maria Horta e Vale, Guilherme Macedo. Management of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroids. World Journal of Hepatology 2014; 6(6): 410-418 doi: 10.4254/wjh.v6.i6.410
|
| 11 |
M. M. Tannous, J. Cheng, K. Muniyappa, I. Farooq, A. Bharara, M. Kappus, V. Luketic, R. T. Stravtiz, M. Fuchs, P. Puri, A. Sanyal, R. Sterling. Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience. Alimentary Pharmacology & Therapeutics 2011; 34(3): 405 doi: 10.1111/j.1365-2036.2011.04749.x
|
| 12 |
Rodrigo Liberal, Edward L. Krawitt, John M. Vierling, Michael P. Manns, Giorgina Mieli-Vergani, Diego Vergani. Cutting edge issues in autoimmune hepatitis. Journal of Autoimmunity 2016; 75: 6 doi: 10.1016/j.jaut.2016.07.005
|
| 13 |
Qi-Xia Wang, Li Yan, Xiong Ma. Autoimmune Hepatitis in the Asia-Pacific Area. Journal of Clinical and Translational Hepatology 2018; 6(1): 1 doi: 10.14218/JCTH.2017.00032
|
| 14 |
Claudia S. Bovensiepen, Miriam Schakat, Marcial Sebode, Roman Zenouzi, Johannes Hartl, Moritz Peiseler, Jun Li, Lara Henze, Anna Woestemeier, Christoph Schramm, Ansgar W. Lohse, Johannes Herkel, Christina Weiler-Normann. TNF-Producing Th1 Cells Are Selectively Expanded in Liver Infiltrates of Patients with Autoimmune Hepatitis. The Journal of Immunology 2019; 203(12): 3148 doi: 10.4049/jimmunol.1900124
|
| 15 |
A. D. YEOMAN, M. S. LONGHI, M. A. HENEGHAN. Review article: the modern management of autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2010; 31(8): 771 doi: 10.1111/j.1365-2036.2010.04241.x
|
| 16 |
R. Liberal, Y. S. de Boer, R. J. Andrade, G. Bouma, G. N. Dalekos, A. Floreani, D. Gleeson, G. M. Hirschfield, P. Invernizzi, M. Lenzi, A. W. Lohse, G. Macedo, P. Milkiewicz, B. Terziroli, B. van Hoek, J. M. Vierling, M. A. Heneghan. Expert clinical management of autoimmune hepatitis in the real world. Alimentary Pharmacology & Therapeutics 2017; 45(5): 723 doi: 10.1111/apt.13907
|
| 17 |
Joanna Ramirez Marlaka, Nikos Papadogiannakis, Björn Fischler, Thomas H. Casswall, Eva Beijer, Antal Németh. Tacrolimus without or with the addition of conventional immunosuppressive treatment in juvenile autoimmune hepatitis. Acta Paediatrica 2012; 101(9): 993 doi: 10.1111/j.1651-2227.2012.02745.x
|
| 18 |
Rinaldo Pellicano, Arianna Ferro, Francesca Cicerchia, Simone Mattivi, Sharmila Fagoonee, Marilena Durazzo. Autoimmune Hepatitis and Fibrosis. Journal of Clinical Medicine 2023; 12(5): 1979 doi: 10.3390/jcm12051979
|
| 19 |
Albert J Czaja. Drug choices in autoimmune hepatitis: Part B – nonsteroids. Expert Review of Gastroenterology & Hepatology 2012; 6(5): 617 doi: 10.1586/egh.12.38
|
| 20 |
Jérôme Dumortier, Carlos Torres Arita, Christine Rivet, Catherine LeGall, Raymonde Bouvier, Nicole Fabien, Olivier Guillaud, Sophie Collardeau-Frachon, Jean-Yves Scoazec, Alain Lachaux. Long-term treatment reduction and steroids withdrawal in children with autoimmune hepatitis: a single centre experience on 55 children. European Journal of Gastroenterology & Hepatology 2009; 21(12): 1413 doi: 10.1097/MEG.0b013e32832ad5f7
|
| 21 |
Ignasi Olivas, Sergio Rodríguez-Tajes, Maria Carlota Londoño. Hepatitis autoinmune: retos y novedades. Medicina Clínica 2022; 159(6): 289 doi: 10.1016/j.medcli.2022.04.004
|
| 22 |
Stuart K. Roberts, Simone I. Strasser, Amanda J. Nicoll, William Kemp, Ammar Majeed, Joanne Mitchell, Katherine Stuart, Paul Gow, Siddharth Sood, Gerry MacQuillan, Jacob George, Jonathan Mitchell, Geoffrey W. McCaughan. Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitis. Scandinavian Journal of Gastroenterology 2020; 55(11): 1309 doi: 10.1080/00365521.2020.1821764
|
| 23 |
Jonah N. Rubin, Helen S. Te. Refractory Autoimmune Hepatitis: Beyond Standard Therapy. Digestive Diseases and Sciences 2016; 61(6): 1757 doi: 10.1007/s10620-015-4022-0
|
| 24 |
Albert J. Czaja, Michael P. Manns. Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis. Gastroenterology 2010; 139(1): 58 doi: 10.1053/j.gastro.2010.04.053
|
| 25 |
Palak J. Trivedi, Gideon M. Hirschfield. Treatment of autoimmune liver disease: current and future therapeutic options. Therapeutic Advances in Chronic Disease 2013; 4(3): 119 doi: 10.1177/2040622313478646
|
| 26 |
Diego Vergani, Giorgina Mieli-Vergani. Pharmacological management of autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2011; 12(4): 607 doi: 10.1517/14656566.2011.524206
|
| 27 |
Annarosa Floreani, Rodrigo Liberal, Diego Vergani, Giorgina Mieli-Vergani. Autoimmune hepatitis: Contrasts and comparisons in children and adults – A comprehensive review. Journal of Autoimmunity 2013; 46: 7 doi: 10.1016/j.jaut.2013.08.004
|
| 28 |
|
| 29 |
V.M. Navas-López, J. Blasco Alonso, M.J. Serrano Nieto, F. Girón Fernández-Crehuet, M.D. Argos Rodriguez, C. Sierra Salinas. Oral tacrolimus for pediatric steroid-resistant ulcerative colitis. Journal of Crohn's and Colitis 2014; 8(1): 64 doi: 10.1016/j.crohns.2013.03.006
|
| 30 |
Rodrigo Liberal, Ynto S de Boer, Michael A Heneghan. Established and novel therapeutic options for autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 2021; 6(4): 315 doi: 10.1016/S2468-1253(20)30328-9
|
| 31 |
Binod Kumar, Akshaya Ramachandran, Gulam Waris. Hepatitis C - From Infection to Cure. 2018; doi: 10.5772/intechopen.75916
|
| 32 |
|
| 33 |
Shuhao Yu, Zhizhong Guo, Yan Guan, Yi-Yu Lu, Pei Hao, Yixue Li, Shi-Bing Su. Combining ZHENG Theory and High-Throughput Expression Data to Predict New Effects of Chinese Herbal Formulae. Evidence-Based Complementary and Alternative Medicine 2012; 2012: 1 doi: 10.1155/2012/986427
|
| 34 |
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6): 681 doi: 10.1586/egh.09.53
|
| 35 |
Shiv K. Sarin, Ashok Choudhury. Acute-on-chronic liver failure: terminology, mechanisms and management. Nature Reviews Gastroenterology & Hepatology 2016; 13(3): 131 doi: 10.1038/nrgastro.2015.219
|
| 36 |
Carlos Ferre-Aracil, Mar Riveiro-Barciela, María Trapero-Marugán, Manuel Rodríguez-Perálvarez, Laura-Patricia Llovet, Luis Téllez, Yolanda Sánchez-Torrijos, Fernando Díaz-Fontenla, Magdalena Salcedo-Plaza, Patricia Álvarez-López, Manuel de la Mata, María-Carlota Londoño, Rafael Bañares-Cañizares, José Luis Calleja. Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study. Digestive Diseases and Sciences 2021; 66(8): 2826 doi: 10.1007/s10620-020-06569-9
|
| 37 |
Dinesh Jothimani, Matthew E Cramp, Jonathon D Mitchell, Tim J S Cross. Treatment of autoimmune hepatitis: A review of current and evolving therapies. Journal of Gastroenterology and Hepatology 2011; 26(4): 619 doi: 10.1111/j.1440-1746.2010.06579.x
|
| 38 |
Luigi Muratori, Maria Serena Longhi. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. Journal of Autoimmunity 2013; 46: 74 doi: 10.1016/j.jaut.2013.06.016
|
| 39 |
Cumali Efe, Haider Al Taii, Henriette Ytting, Niklas Aehling, Rahima A. Bhanji, Hannes Hagström, Tugrul Purnak, Luigi Muratori, Mårten Werner, Paolo Muratori, Daniel Klintman, Thomas D. Schiano, Aldo J. Montano-Loza, Thomas Berg, Fin Stolze Larsen, Naim Alkhouri, Ersan Ozaslan, Michael A. Heneghan, Eric M. Yoshida, Staffan Wahlin. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. Digestive Diseases and Sciences 2018; 63(5): 1348 doi: 10.1007/s10620-018-5011-x
|
| 40 |
Mohamad Hanouneh, Michael M. Ritchie, Mona Ascha, Mustafa S. Ascha, Alice Chedid, Anawin Sanguankeo, Nizar N. Zein, Ibrahim A. Hanouneh. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis. Scandinavian Journal of Gastroenterology 2019; 54(1): 76 doi: 10.1080/00365521.2018.1551498
|
| 41 |
Albert J Czaja. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Review of Gastroenterology & Hepatology 2013; 7(4): 365 doi: 10.1586/egh.13.21
|
| 42 |
Rubén Peña-Vélez, Enory Almanza-Miranda. Hepatitis autoinmune en la edad pediátrica. Boletín Médico del Hospital Infantil de México 2017; 74(5): 324 doi: 10.1016/j.bmhimx.2017.05.004
|
| 43 |
Albert J Czaja. Safety issues in the management of autoimmune hepatitis. Expert Opinion on Drug Safety 2008; 7(3): 319 doi: 10.1517/14740338.7.3.319
|
| 44 |
Simon Pape, Frederik Nevens, Chris Verslype, Caroline Mertens, Joost P.H. Drenth, Eric T.T.L. Tjwa. Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience. European Journal of Gastroenterology & Hepatology 2020; 32(6): 727 doi: 10.1097/MEG.0000000000001580
|
| 45 |
Richard Parker, Ye Htun Oo, David H. Adams. Management of patients with difficult autoimmune hepatitis. Therapeutic Advances in Gastroenterology 2012; 5(6): 421 doi: 10.1177/1756283X12450251
|
| 46 |
Gideon M. Hirschfield, Nadya Al-Harthi, E. Jenny Heathcote. Review: Current status of therapy in autoimmune liver disease. Therapeutic Advances in Gastroenterology 2009; 2(1): 11 doi: 10.1177/1756283X08098966
|
| 47 |
P. J. Trivedi, G. M. Hirschfield. Review article: overlap syndromes and autoimmune liver disease. Alimentary Pharmacology & Therapeutics 2012; 36(6): 517 doi: 10.1111/j.1365-2036.2012.05223.x
|
| 48 |
EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015; 63(4): 971 doi: 10.1016/j.jhep.2015.06.030
|
| 49 |
Joanna Vitfell‐Pedersen, Marianne Hørby Jørgensen, Klaus Müller, Carsten Heilmann. Autoimmune Hepatitis in Children in Eastern Denmark. Journal of Pediatric Gastroenterology and Nutrition 2012; 55(4): 376 doi: 10.1097/MPG.0b013e3182602b20
|
| 50 |
Qixia Wang, Fan Yang, Qi Miao, Edward L. Krawitt, M. Eric Gershwin, Xiong Ma. The clinical phenotypes of autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2016; 66: 98 doi: 10.1016/j.jaut.2015.10.006
|
| 51 |
Ashnila Janmohamed, Gideon M Hirschfield. Autoimmune hepatitis and complexities in management. Frontline Gastroenterology 2019; 10(1): 77 doi: 10.1136/flgastro-2018-101015
|
| 52 |
Albert J Czaja. Current and future treatments of autoimmune hepatitis. Expert Review of Gastroenterology & Hepatology 2009; 3(3): 269 doi: 10.1586/egh.09.15
|
| 53 |
Nicole MF van Gerven, Ynto S de Boer, Chris JJ Mulder, Carin MJ van Nieuwkerk, Gerd Bouma. Auto immune hepatitis. World Journal of Gastroenterology 2016; 22(19): 4651-4661 doi: 10.3748/wjg.v22.i19.4651
|
| 54 |
Edward L Krawitt. Clinical features and management of autoimmune hepatitis. World Journal of Gastroenterology 2008; 14(21): 3301-3305 doi: 10.3748/wjg.14.3301
|
| 55 |
Shiv Kumar Sarin, Ashok Choudhury. Management of acute-on-chronic liver failure: an algorithmic approach. Hepatology International 2018; 12(5): 402 doi: 10.1007/s12072-018-9887-5
|
| 56 |
V. Selvarajah, A. J. Montano‐Loza, A. J. Czaja. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Alimentary Pharmacology & Therapeutics 2012; 36(8): 691 doi: 10.1111/apt.12042
|
| 57 |
Cumali Efe, Hannes Hagström, Henriette Ytting, Rahima A. Bhanji, Niklas F. Müller, Qixia Wang, Tugrul Purnak, Luigi Muratori, Mårten Werner, Hanns-Ulrich Marschall, Paolo Muratori, Fulya Gunşar, Daniel Klintman, Albert Parés, Alexandra Heurgué–Berlot, Thomas D. Schiano, Mustafa Cengiz, Michele May-Sien Tana, Xiong Ma, Aldo J. Montano-Loza, Thomas Berg, Sumita Verma, Fin Stolze Larsen, Ersan Ozaslan, Michael A. Heneghan, Eric M. Yoshida, Staffan Wahlin. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 2017; 15(12): 1950 doi: 10.1016/j.cgh.2017.06.001
|
| 58 |
A. J. Czaja. Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2014; 39(4): 385 doi: 10.1111/apt.12592
|
| 59 |
Henriette Ytting, Fin Stolze Larsen. Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use. Scandinavian Journal of Gastroenterology 2015; 50(8): 1025 doi: 10.3109/00365521.2014.998271
|
| 60 |
Lars Bossen, Alessio Gerussi, Vasiliki Lygoura, George F. Mells, Marco Carbone, Pietro Invernizzi. Support of precision medicine through risk-stratification in autoimmune liver diseases – histology, scoring systems, and non-invasive markers. Autoimmunity Reviews 2018; 17(9): 854 doi: 10.1016/j.autrev.2018.02.013
|
| 61 |
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Liver Immunology. 2020; : 419 doi: 10.1007/978-3-030-51709-0_26
|
| 62 |
Ignasi Olivas, Sergio Rodriguez-Tajes, Maria Carlota Londoño. Autoimmune hepatitis: Challenges and novelties. Medicina Clínica (English Edition) 2022; 159(6): 289 doi: 10.1016/j.medcle.2022.08.008
|
| 63 |
A. J. Czaja. Review article: the management of autoimmune hepatitis beyond consensus guidelines. Alimentary Pharmacology & Therapeutics 2013; 38(4): 343 doi: 10.1111/apt.12381
|
| 64 |
Mussarat N. Rahim, Rodrigo Liberal, Rosa Miquel, Nigel D. Heaton, Michael A. Heneghan. Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation?. Liver Transplantation 2019; 25(6): 946 doi: 10.1002/lt.25451
|
| 65 |
Anna E. C. Stoelinga, Maarten E. Tushuizen, Wilbert B. van den Hout, Mar D. M. Rodriguez Girondo, Elsemieke S. de Vries, Amar D. Levens, Dirk-Jan A. R. Moes, Tom J. G. Gevers, Suzanne van der Meer, Hans T. Brouwer, Hendrik J. M. de Jonge, Ynte S. de Boer, Ulrich H. W. Beuers, Adriaan J. van der Meer, Aad P. van den Berg, Maureen M. J. Guichelaar, Joost P. H. Drenth, Bart van Hoek, Sjoerd F. Bakker, JM Vrolijk, Patrick van der Veek, Nicole F. van Gerven. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial. Trials 2024; 25(1) doi: 10.1186/s13063-023-07832-w
|
| 66 |
Sina Hübener, Ye Htun Oo, Nwe Ni Than, Peter Hübener, Christina Weiler-Normann, Ansgar W. Lohse, Christoph Schramm. Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance. Clinical Gastroenterology and Hepatology 2016; 14(3): 445 doi: 10.1016/j.cgh.2015.09.037
|
| 67 |
|
| 68 |
Loris Lopetuso, Giammarco Mocci, Manuela Marzo, Francesca D’Aversa, Gian Rapaccini, Luisa Guidi, Alessandro Armuzzi, Antonio Gasbarrini, Alfredo Papa. Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver. International Journal of Molecular Sciences 2018; 19(8): 2199 doi: 10.3390/ijms19082199
|
| 69 |
|
| 70 |
Albert J Czaja. Current and prospective pharmacotherapy for autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2014; 15(12): 1715 doi: 10.1517/14656566.2014.931938
|
| 71 |
Dhruv Lowe, Savio John. Autoimmune hepatitis: Appraisal of current treatment guidelines. World Journal of Hepatology 2018; 10(12): 911-923 doi: 10.4254/wjh.v10.i12.911
|
| 72 |
Mohammadreza Abdollahi, Neda Khalilian Ekrami, Morteza Ghojazadeh, H Marike Boezen, Mohammadhossein Somi, Behrooz Z Alizadeh. Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?. World Journal of Gastroenterology 2020; 26(38): 5896-5910 doi: 10.3748/wjg.v26.i38.5896
|
| 73 |
Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger, Thomas Berg. Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies. Journal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/9437043
|
| 74 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World Journal of Gastroenterology 2017; 23(33): 6030-6048 doi: 10.3748/wjg.v23.i33.6030
|
| 75 |
Iliana Doycheva, Kymberly D. Watt, Aliya F. Gulamhusein. Autoimmune hepatitis: Current and future therapeutic options. Liver International 2019; 39(6): 1002 doi: 10.1111/liv.14062
|
| 76 |
Christina Weiler-Normann, Christoph Schramm, Alexander Quaas, Christiane Wiegard, Claudia Glaubke, Nadine Pannicke, Sina Möller, Ansgar W. Lohse. Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. Journal of Hepatology 2013; 58(3): 529 doi: 10.1016/j.jhep.2012.11.010
|
| 77 |
Diego Vergani, Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani. A reasoned approach to the treatment of autoimmune hepatitis. Digestive and Liver Disease 2021; 53(11): 1381 doi: 10.1016/j.dld.2021.05.033
|
| 78 |
Lovkesh Anand, Ashok Choudhury, Chhagan Bihari, Barjesh C. Sharma, Manoj Kumar, Rakhi Maiwall, Soek Siam Tan, Samir R. Shah, Saeed Hamid, Amna S. Butt, Wasim Jafri, Yogesh K. Chawla, Sunil Taneja, Ajay Duseja, Radha K. Dhiman, Mamun Al Mahtab, Hasmik Ghazinyan, Zhongping Duan, Yu Chen, Akash Shukla, Jinhua Hu, Zaigham Abbas, Sombat Treeprasertsuk, Laurentius A. Lesmana, Cosmas R Lesmana, Jose D. Sollano, Gian Carpio, Manoj K. Sahu, Guresh Kumar, Shiv K. Sarin. Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy. Hepatology 2019; 70(2): 587 doi: 10.1002/hep.30205
|
| 79 |
Pinelopi Arvaniti, Ignasi Olivas, Sergio Rodriguez-Tajes, George N. Dalekos, Maria-Carlota Londoño. Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand?. Exploration of Digestive Diseases 2024; : 92 doi: 10.37349/edd.2024.00042
|
| 80 |
Yooyun Chung, Mussarat N Rahim, Jonathon J Graham, Yoh Zen, Michael A Heneghan. An update on the pharmacological management of autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2021; 22(11): 1475 doi: 10.1080/14656566.2021.1895747
|
| 81 |
Hemant Chatrath, Larissa Allen, Thomas D. Boyer. Use of Sirolimus in the Treatment of Refractory Autoimmune Hepatitis. The American Journal of Medicine 2014; 127(11): 1128 doi: 10.1016/j.amjmed.2014.06.016
|
| 82 |
Keaton R. Jones, Craig S. Lammert. Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies. Current Hepatology Reports 2018; 17(3): 166 doi: 10.1007/s11901-018-0401-2
|
| 83 |
John M. Vierling. Autoimmune Hepatitis and Overlap Syndromes: Diagnosis and Management. Clinical Gastroenterology and Hepatology 2015; 13(12): 2088 doi: 10.1016/j.cgh.2015.08.012
|
| 84 |
Georgios Giannakopoulos, Hans Verbaan, Inga-Lill Friis-Liby, Per Sangfelt, Nils Nyhlin, Sven Almer. Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine. Digestive and Liver Disease 2019; 51(2): 253 doi: 10.1016/j.dld.2018.10.004
|
| 85 |
Ansgar W. Lohse, Christina Weiler-Normann. Zakim and Boyer's Hepatology. 2018; : 594 doi: 10.1016/B978-0-323-37591-7.00041-0
|